Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury

Osteoporosis International

Volumn 22, Issue 1, 2011, Pages 271-279

  Bubbear, J S ^a   Gall, A ^a   Middleton, F R I ^a   Ferguson Pell, M ^b   Swaminathan, R ^c   Keen, R W ^a,d  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonate; Osteoporosis; Spinal cord injury; Zoledronic acid

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; PROCOLLAGEN; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FEVER; FLU LIKE SYNDROME; HIP; HUMAN; LUMBAR SPINE; MALE; MYALGIA; NOSE CONGESTION; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE INJURY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIP JOINT; HUMANS; IMIDAZOLES; LUMBAR VERTEBRAE; MALE; OSTEOPOROSIS; SPINAL CORD INJURIES; YOUNG ADULT;

EID: 78651479175     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1221-6     Document Type: Article

References (23)

1. F Biering-Sorensen HH Bohr OP Schaadt 1990 Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury Eur J Clin Invest 20 330 335 1:STN:280:DyaK3czhs1WmtQ%3D%3D 10.1111/j.1365-2362.1990.tb01865.x 2114994
2. WM Nottage 1981 A review of long-bone fractures in patients with spinal cord injuries Clin Orthop Relat Res 155 65 70 7226633
3. P Vestergaard K Krogh L Rejnmark L Mosekilde 1998 Fracture rates and risk factors for fractures in patients with spinal cord injury Spinal Cord 36 790 796 1:STN:280:DyaK1M%2Fmtlagtg%3D%3D 10.1038/sj.sc.3100648 9848488
4. P Pietschmann P Pils W Woloszczuk R Maerk D Lessan J Stipicic 1992 Increased serum osteocalcin levels in patients with paraplegia Paraplegia 30 204 209 1:STN:280:DyaK38zjsV2jsA%3D%3D 1630849
5. D Roberts W Lee RC Cuneo J Wittmann G Ward R Flatman B McWhinney PE Hickman 1998 Longitudinal study of bone turnover after acute spinal cord injury J Clin Endocrinol Metab 83 415 422 1:CAS:528:DyaK1cXpvFelug%3D%3D 10.1210/jc.83.2.415 9467550
6. L Maimoun I Couret JP Micallef E Peruchon D Mariano-Goulart M Rossi JL Leroux F Ohanna 2002 Use of bone biochemical markers with dual-energy X-ray absorptiometry for early determination of bone loss in persons with spinal cord injury Metabolism 51 958 963 1:CAS:528:DC%2BD38XlvV2hs7s%3D 10.1053/meta.2002. 34013 12145766
7. D Chappard P Minaire C Privat E Berard J Mendoza-Sarmiento H Tournebise MF Basle M Audran A Rebel C Picot 1995 Effects of tiludronate on bone loss in paraplegic patients J Bone Miner Res 10 112 118 1:STN:280:DyaK2M3ms1Cmuw%3D%3D 10.1002/jbmr.5650100116 7747617
8. Y Zehnder S Risi D Michel H Knecht R Perrelet M Kraenzlin GA Zach K Lippuner 2004 Prevention of bone loss in paraplegics over 2 years with alendronate J Bone Miner Res 19 1067 1074 1:CAS:528:DC%2BD2cXlvFWrtro%3D 10.1359/JBMR.040313 15176988
9. EG Pearson PW Nance WD Leslie S Ludwig 1997 Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury Arch Phys Med Rehabil 78 269 272 1:STN:280:DyaK2s3jvVSisw%3D%3D 10.1016/S0003-9993(97)90032-0 9084348
10. PW Nance O Schryvers W Leslie S Ludwig J Krahn D Uebelhart 1999 Intravenous pamidronate attenuates bone density loss after acute spinal cord injury Arch Phys Med Rehabil 80 243 251 1:STN:280:DyaK1M7otF2hsw%3D%3D 10.1016/S0003-9993(99)90133-8 10084430
11. JR Green K Muller KA Jaeggi 1994 Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound J Bone Miner Res 9 745 751 1:CAS:528:DyaK2cXlt1Gitro%3D 10.1002/jbmr.5650090521 8053405
12. IR Reid JP Brown P Burckhardt Z Horowitz P Richardson U Trechsel A Widmer JP Devogelaer JM Kaufman P Jaeger JJ Body ML Brandi J Broell R Di Micco AR Genazzani D Felsenberg J Happ MJ Hooper J Ittner G Leb H Mallmin T Murray S Ortolani A Rubinacci M Saaf G Samsioe L Verbruggen PJ Meunier 2002 Intravenous zoledronic acid in postmenopausal women with low bone mineral density N Engl J Med 346 653 661 1:CAS:528:DC%2BD38XhsFOjsrw%3D 10.1056/NEJMoa011807 11870242
13. DM Black PD Delmas R Eastell IR Reid S Boonen JA Cauley F Cosman P Lakatos PC Leung Z Man C Mautalen P Mesenbrink H Hu J Caminis K Tong T Rosario-Jansen J Krasnow TF Hue D Sellmeyer EF Eriksen SR Cummings 2007 Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 1809 1822 1:CAS:528:DC%2BD2sXltVSktLc%3D 10.1056/NEJMoa067312 17476007
14. D Hosking K Lyles JP Brown WD Fraser P Miller MD Curiel JP Devogelaer M Hooper G Su K Zelenakas J Pak T Fashola Y Saidi EF Eriksen IR Reid 2007 Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate J Bone Miner Res 22 142 148 1:CAS:528:DC%2BD2sXhtVWnurg%3D 10.1359/jbmr.061001 17032148
15. DE Wood AL Dunkerley AM Tromans 2001 Results from bone mineral density scans in twenty-two complete lesion paraplegics Spinal Cord 39 145 148 1:STN:280:DC%2BD3Mvit12rsA%3D%3D 10.1038/sj.sc.3101125 11326324
16. M Dauty VB Perrouin Y Maugars C Dubois JF Mathe 2000 Supralesional and sublesional bone mineral density in spinal cord-injured patients Bone 27 305 309 1:STN:280:DC%2BD3cvisVClug%3D%3D 10.1016/S8756-3282(00)00326-4 10913927
17. G Demirel H Yilmaz N Paker S Onel 1998 Osteoporosis after spinal cord injury Spinal Cord 36 822 825 1:STN:280:DyaK1M%2Fps1SmtQ%3D%3D 10.1038/sj.sc.3100704 9881730
18. NL Gilchrist CM Frampton RH Acland MG Nicholls RL March P Maguire A Heard P Reilly K Marshall 2007 Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 92 1385 1390 1:CAS:528:DC%2BD2sXksVSrt7w%3D 10.1210/jc.2006-2013 17227802
19. A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women Endocr Rev 23 508 516 1:CAS:528:DC%2BD38Xnt1Wiur8%3D 10.1210/er.2001-2002 12202465
20. NH Bjarnason EE Henriksen P Alexandersen S Christgau DB Henriksen C Christiansen 2002 Mechanism of circadian variation in bone resorption Bone 30 307 313 1:STN:280:DC%2BD38%2FmvVWltA%3D%3D 10.1016/S8756-3282(01)00662-7 11792602
21. R Hannon R Eastell 2000 Preanalytical variability of biochemical markers of bone turnover Osteoporos Int 11 Suppl 6 S30 S44 10.1007/s001980070004 11193238
22. JA Clowes RA Hannon TS Yap NR Hoyle A Blumsohn R Eastell 2002 Effect of feeding on bone turnover markers and its impact on biological variability of measurements Bone 30 886 890 1:STN:280:DC%2BD38zhtVSgug%3D%3D 10.1016/S8756-3282(02)00728-7 12052458
23. JK Scariano PJ Garry GD Montoya JM Wilson RN Baumgartner 2001 Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women Clin Biochem 34 639 644 1:CAS:528:DC%2BD38XisVGlurc%3D 10.1016/S0009-9120(01)00273-9 11849624